Literature DB >> 14708711

HLA-G modulates immune responses by diverse receptor interactions.

Valeska Hofmeister1, Elisabeth H Weiss.   

Abstract

HLA-G regulates immune responses as it binds different receptors expressed on natural killer (NK) cells, T cells and myeloid cells. HLA-G1 can inhibit NK- and T-cell-mediated lysis of target cells by its interaction with the inhibitory receptors ILT2 and ILT4. Engaging KIR2DL4 triggers different reactions depending on the activation state of the effector cells. The indirect recognition of HLA-G as peptide presented by HLA-E and recognized by the CD94/NKG2 receptor family might further power the battle between the immune system and tumor cells. Secreted HLA-G5 can also bind CD8 and induces Fas/Fas ligand-mediated apoptosis in activated CD8+ lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14708711     DOI: 10.1016/s1044-579x(03)00022-1

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  21 in total

1.  Isoforms of the nonclassical class I MHC antigen H2-Q5 are enriched in brain and encode Qdm peptide.

Authors:  Nora E Renthal; Paula A Guidry; Sharmila Shanmuganad; William Renthal; Iwona Stroynowski
Journal:  Immunogenetics       Date:  2010-10-22       Impact factor: 2.846

2.  Crystal structure of HLA-G: a nonclassical MHC class I molecule expressed at the fetal-maternal interface.

Authors:  Craig S Clements; Lars Kjer-Nielsen; Lyudmila Kostenko; Hilary L Hoare; Michelle A Dunstone; Eric Moses; Katy Freed; Andrew G Brooks; Jamie Rossjohn; James McCluskey
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-17       Impact factor: 11.205

3.  Mechanisms of malignant glioma immune resistance and sources of immunosuppression.

Authors:  German G Gomez; Carol A Kruse
Journal:  Gene Ther Mol Biol       Date:  2006

4.  TEG011 persistence averts extramedullary tumor growth without exerting off-target toxicity against healthy tissues in a humanized HLA-A*24:02 transgenic mice.

Authors:  Inez Johanna; Patricia Hernández-López; Sabine Heijhuurs; Laura Bongiovanni; Alain de Bruin; Dennis Beringer; Sanne van Dooremalen; Leonard D Shultz; Fumihiko Ishikawa; Zsolt Sebestyen; Trudy Straetemans; Jürgen Kuball
Journal:  J Leukoc Biol       Date:  2020-02-05       Impact factor: 4.962

Review 5.  Immunology of hepatic diseases during pregnancy.

Authors:  Lars Bremer; Christoph Schramm; Gisa Tiegs
Journal:  Semin Immunopathol       Date:  2016-06-20       Impact factor: 9.623

6.  Different natural killer (NK) receptor expression and immunoglobulin E (IgE) regulation by NK1 and NK2 cells.

Authors:  E Aktas; M Akdis; S Bilgic; R Disch; C S Falk; K Blaser; C Akdis; G Deniz
Journal:  Clin Exp Immunol       Date:  2005-05       Impact factor: 4.330

7.  The HLA-G*0105N null allele induces cell surface expression of HLA-E molecule and promotes CD94/NKG2A-mediated recognition in JAR choriocarcinoma cell line.

Authors:  Frédéric G Sala; Pierre-Marie Del Moral; Nathalie Pizzato; Florence Legrand-Abravanel; Philippe Le Bouteiller; Françoise Lenfant
Journal:  Immunogenetics       Date:  2004-11-13       Impact factor: 2.846

8.  Regulation of cytotoxic T lymphocyte triggering by PIR-B on dendritic cells.

Authors:  Shota Endo; Yuzuru Sakamoto; Eiji Kobayashi; Akira Nakamura; Toshiyuki Takai
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-11       Impact factor: 11.205

9.  Variable gene expression and parasite load predict treatment outcome in cutaneous leishmaniasis.

Authors:  Camila Farias Amorim; Fernanda O Novais; Ba T Nguyen; Ana M Misic; Lucas P Carvalho; Edgar M Carvalho; Daniel P Beiting; Phillip Scott
Journal:  Sci Transl Med       Date:  2019-11-20       Impact factor: 17.956

Review 10.  Inhibition of host immune response in colorectal cancer: human leukocyte antigen-G and beyond.

Authors:  Marica Garziera; Giuseppe Toffoli
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.